Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study

BACKGROUND: Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and benzodiazepine anxiolytics are used in the US to treat generalized anxiety disorder (GAD). While benzodiazepines typically provide rapid symptomatic relief, long-term use is not recommended due to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Berger, Ariel, Edelsberg, John, Treglia, Michael, Alvir, Jose Ma J, Oster, Gerry
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2012
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3504522/
https://ncbi.nlm.nih.gov/pubmed/23088742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-12-177
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi